Schor Chen has filed 11 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 468555 shares of Adicet Bio, Inc. ($ACET) on March 25, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | Adicet Bio, Inc. | $ACET | Schor Chen | President & CEO | A | Stock Option (Right to Buy) | 468555 | $0.00 | 468,555.0000 | 153,255,581 | 9999.99% | 0.31% |
| Jan. 24, 2026 | Adicet Bio, Inc. | $ACET | Schor Chen | President & CEO | F | Common Stock | 1755 | $8.44 | 12,875.0000 | 153,255,581 | 12.00% | 0.00% |
| May 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Schor Chen | Not found | A | Nonstatutory Stock Option (right to buy) | 4600 | $0.00 | 4,600.0000 | 126,240,054 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Adicet Bio, Inc. | $ACET | Schor Chen | President & CEO | A | Stock Option (Right to Buy) | 763829 | $0.00 | 763,829.0000 | 0 | 9999.99% | 0.00% |
| Jan. 24, 2025 | Adicet Bio, Inc. | $ACET | Schor Chen | President & CEO | F | Common Stock | 28101 | $0.92 | 234,094.0000 | 0 | 10.72% | 0.00% |
| June 5, 2024 | Adicet Bio, Inc. | $ACET | Schor Chen | President & CEO | A | Stock Option (Right to Buy) | 1770427 | $0.00 | 1,770,427.0000 | 0 | 9999.99% | 0.00% |
| May 29, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Schor Chen | Not found | A | Nonstatutory Stock Option (right to buy) | 69000 | $0.00 | 69,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 24, 2024 | Adicet Bio, Inc. | $ACET | Schor Chen | President & CEO | A | Common Stock | 70300 | $0.00 | 305,664.0000 | 0 | 29.87% | 0.00% |
| Jan. 24, 2024 | Adicet Bio, Inc. | $ACET | Schor Chen | President & CEO | F | Common Stock | 15290 | $2.40 | 235,364.0000 | 0 | 6.10% | 0.00% |
| Jan. 24, 2024 | Adicet Bio, Inc. | $ACET | Schor Chen | President & CEO | A | Stock Option (Right to Buy) | 1116903 | $0.00 | 1,116,903.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Karyopharm Therapeutics Inc. | $KPTI | Schor Chen | Director | A | Nonstatutory Stock Option (right to buy) | 34000 | $0.00 | 34,000.0000 | 0 | 9999.99% | 0.00% |